V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009493 | 310007971 | 1.74 | 55.6 | Curative (C) | 2013-11-24 | 2013-11-29 | Ipilimumab | N | N | 310018466 | IPILIMUMAB |
| 310009494 | 310004634 | null | 60 | Palliative (P) | 2013-06-23 | 2013-09-02 | CARBOPLATIN + ETOPOSIDE | 2 | N | 310018467 | CARBOPLATIN + ETOPOSIDE |
| 310009495 | 310004640 | 1.85 | 57.25 | Disease modification (D) | 2017-11-29 | 2017-12-01 | Bexarotene | null | null | 310018472 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310009496 | 310004641 | 1.78 | null | Adjuvant (A) | null | 2018-06-22 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 310018476 | CISPLATIN + RT |
| 310009497 | 310004641 | 1.9 | 84 | Curative (C) | 2019-07-28 | 2019-07-28 | Cyclophosphamide High Dose | N | N | 310018476 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009498 | 310004644 | 1.69 | 112.1 | null | 2014-08-05 | 2014-08-20 | CHOP R | N | N | 310018482 | CHOP R |
| 310009499 | 310007979 | 1.7 | 52.2 | Curative (C) | 2017-01-16 | 2017-10-03 | Cisplatin + Radiotherapy | N | N | 310018495 | CISPLATIN + RT |
| 310009500 | 310004649 | 1.63 | 62.3 | Curative (C) | 2015-08-29 | 2016-02-20 | Etoposide oral | N | N | 310018504 | ETOPOSIDE |
| 310009501 | 310004657 | 0 | 76 | Disease modification (D) | 2017-03-03 | 2017-03-04 | Methotrexate Intrathecal (any age) | N | N | 310018510 | METHOTREXATE INTRATHECAL |
| 310009502 | 310004659 | 1.58 | 69 | null | 2017-03-27 | 2017-04-05 | Cisplatin | N | N | 310018514 | CISPLATIN |
| 310009503 | 310004660 | 1.85 | 77.7 | Palliative (P) | 2014-06-19 | 2014-06-19 | CHOP R - 21 days | N | N | 310018518 | CHOP R |
| 310009504 | 310004661 | 1.61 | null | null | null | 2018-02-26 | CARBOPLATIN + ETOPOSIDE | null | null | 310018522 | ESHAP |
| 310009505 | 310004662 | 1.59 | 55.8 | Curative (C) | 2014-10-25 | 2014-11-28 | GDP | N | N | 310018529 | GDP |
| 310009506 | 310004665 | 1.8 | 82 | Palliative (P) | 2017-05-04 | 2017-05-05 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 310018530 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009507 | 310004667 | null | 72 | Curative (C) | 2017-04-20 | 2017-06-01 | Docetaxel 75mg/m2 (21 day) | null | null | 310018536 | DOCETAXEL |
| 310009508 | 310004669 | 1.61 | 61.9 | Palliative (P) | 2019-01-26 | 2019-01-28 | GDP | 99 | null | 310018537 | GDP |
| 310009509 | 310004674 | 1.9 | 71 | Curative (C) | 2017-06-26 | 2017-06-27 | GDP | N | N | 310018548 | GDP |
| 310009511 | 310004678 | 0 | 71 | Curative (C) | 2016-02-28 | 2016-02-28 | Cyclophosphamide High Dose | 2 | N | 310018568 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009512 | 310004681 | 1.71 | 79.4 | Curative (C) | 2015-09-14 | 2015-10-10 | CHOP R - 14 days | N | N | 310018574 | CHOP R |
| 310009513 | 310004684 | 1.71 | 66.8 | Curative (C) | 2017-07-03 | 2017-07-04 | GDP | 02 | N | 310018582 | GDP |
| 310009514 | 310004686 | 1.6 | 77.5 | Curative (C) | null | 2014-11-20 | GDP | N | Y | 310018584 | GDP |
| 310009515 | 310004687 | 1.76 | 72.5 | Palliative (P) | 2014-04-03 | 2014-06-18 | Bevacizumab+Carbo+Pacliaxel | N | N | 310018588 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009516 | 310004689 | 0 | 140 | null | 2014-12-28 | 2014-03-17 | Methotrexate intrathecal | 2 | N | 310018590 | METHOTREXATE INTRATHECAL |
| 310009517 | 310004692 | 1.75 | 55.5 | null | 2018-02-05 | 2018-02-11 | Bexarotene | N | N | 310018600 | BEXAROTENE |
| 310009518 | 310004693 | 1.74 | 59.8 | Curative (C) | 2015-12-03 | 2016-03-18 | Methotrexate intrathecal | 02 | N | 310018602 | METHOTREXATE INTRATHECAL |
| 310009519 | 310009770 | 1.57 | 50 | Curative (C) | null | 2014-07-29 | Ipilimumab | N | null | 310018605 | IPILIMUMAB |
| 310009520 | 310004697 | null | 102.4 | Palliative (P) | null | 2018-04-12 | Methotrexate Intrathecal (any age) | N | null | 310018615 | METHOTREXATE INTRATHECAL |
| 310009521 | 310004700 | 1.62 | 75.7 | Curative (C) | 2016-05-19 | 2016-06-15 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | null | 310018629 | BEXAROTENE |
| 310009522 | 310004702 | 1.7 | 82.8 | Palliative (P) | 2015-12-26 | 2016-02-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310018637 | DOCETAXEL |
| 310009523 | 310004703 | 1.69 | 68.3 | Curative (C) | 2018-08-06 | 2018-08-06 | Methotrexate intrathecal | 02 | null | 310018640 | METHOTREXATE INTRATHECAL |
| 310009524 | 310004704 | 1.63 | 41.4 | Curative (C) | 2012-10-19 | 2013-12-24 | GDP | Y | N | 310018647 | GDP |
| 310009525 | 310004707 | 1.88 | 90.9 | Adjuvant (A) | null | 2019-03-29 | CISPLATIN + RT | N | null | 310018650 | CISPLATIN + RT |
| 310009526 | 310004710 | 0 | 77.7 | Curative (C) | null | 2015-09-23 | Cisplatin | 2 | N | 310018651 | CISPLATIN |
| 310009527 | 310008012 | 1.59 | 88.1 | Curative (C) | 2013-05-30 | 2013-06-01 | Cisplatin | N | N | 310018656 | CISPLATIN |
| 310009528 | 310004715 | null | 74.2 | Disease modification (D) | 2017-01-04 | 2017-01-05 | Carboplatin + Etoposide iv&po | 02 | N | 310018680 | BEXAROTENE |
| 310009529 | 310004718 | 1.73 | 0 | Palliative (P) | 2014-05-14 | 2014-05-23 | GDP | 2 | N | 310018685 | GDP |
| 310009530 | 310004723 | 1.64 | 64.4 | null | 2014-06-28 | 2014-07-04 | Ipilimumab | N | N | 310018688 | IPILIMUMAB |
| 310009531 | 310009775 | 1.58 | null | Palliative (P) | 2016-10-29 | 2016-10-29 | CHOP R | N | N | 310018694 | CHOP R |
| 310009532 | 310004727 | 1.6 | 57 | Disease modification (D) | 2017-07-29 | 2017-11-09 | CYCLOPHOSPHAMIDE | N | N | 310018697 | CYCLOPHOSPHAMIDE |
| 310009533 | 310009776 | 1.73 | 84.4 | Palliative (P) | 2014-05-28 | 2014-05-28 | Methotrexate intrathecal | 02 | N | 310018701 | METHOTREXATE INTRATHECAL |
| 310009534 | 310004731 | null | 104.4 | Neo-adjuvant (N) | 2014-04-16 | 2014-05-17 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 1 | N | 310018701 | ESHAP |
| 310009535 | 310004732 | 1.57 | null | Disease modification (D) | 2014-09-22 | 2014-09-22 | Rituximab | 2 | N | 310018705 | RITUXIMAB |
| 310009536 | 310004733 | 1.58 | 54.3 | Curative (C) | 2016-08-30 | 2017-01-24 | Cisplatin 7 day | 02 | N | 310018713 | CISPLATIN |
| 310009537 | 310004735 | 1.6 | 73 | Palliative (P) | 2015-04-19 | 2015-04-19 | ETOPOSIDE | N | N | 310018717 | ETOPOSIDE |
| 310009538 | 310004736 | 1.74 | null | Palliative (P) | 2015-08-12 | 2015-12-06 | Cyclophosphamide High Dose | 02 | N | 310018718 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009539 | 310004738 | null | 67.25 | Palliative (P) | 2016-01-26 | 2016-04-08 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018723 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009540 | 310004741 | 1.64 | 83 | Curative (C) | 2016-03-11 | 2016-03-21 | Cyclophosphamide High Dose | N | null | 310018729 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009541 | 310004742 | 1.52 | 57 | Palliative (P) | 2018-02-26 | 2018-06-20 | Docetaxel 75mg/m2 (21 day) | N | Y | 310018733 | DOCETAXEL |
| 310009543 | 310004746 | null | 52.7 | Curative (C) | 2016-01-17 | 2016-01-23 | GDP | 2 | N | 310018736 | GDP |
| 310009545 | 310004748 | 1.73 | 85 | Palliative (P) | 2017-02-21 | 2017-08-31 | GDP | N | N | 310018744 | GDP |